Rapid clinical-scale propagation of mesenchymal stem cells using cultures initiated with immunoselected bone marrow CD105 + cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 9, 2011, Pages 1983-1988

  Spiropoulos, Antonia ^a   Theodosaki, Maria ^a   Stefanaki, Kalliopi ^a   Paterakis, George ^b   Tzetis, Maria ^c   Giannikou, Krinio ^c   Petrakou, Eftichia ^a   Dimopoulou, Maria N ^a   Papassotiriou, Ioannis ^a   Roma, Eleptheria S ^a   Kanavakis, Emmanuel ^c   Graphakos, Stelios ^a   Goussetis, Evgenios ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b 'G Genimmatas' General District Hospital   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

CD105 + cells; Clinical scale expansion; Mesenchymal stem cells

Indexed keywords

CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; MIXED LYMPHOCYTE CULTURE;

ADULT; ANTIGENS, CD; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MESENCHYMAL STEM CELLS; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 80052166816     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01157.x     Document Type: Article

References (27)

1. Alhadlaq A, Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 2004; 13: 436-48.
2. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000; 28: 875-84.
3. Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 2008; 17: 1103-13.
4. Keyser KA, Beagles KE, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 2007; 16: 555-62.
5. Ucceli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol. 2006; 36: 2566-73.
6. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005; 11: 389-98.
7. Ning H, Yang F, Jiang M, et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia. 2008; 22: 593-9.
8. Koç O, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000; 18: 307-16.
9. Le Blanc K, Frassoni F, Ball L, et al. Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008; 371: 1579-86.
10. Von Bonin M, Stoelzel F, Goedecke A, et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009; 43: 245-51.
11. Awaya N, Rupert K, Bryant E, et al. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol. 2002; 30: 937-42.
12. Ismail M, Gibson FM, Marks K, et al. Combined immunocytochemistry and FISH: an improved method to study engraftment of accessory bone marrow stromal cells. Clin Lab Haematol. 2002; 24: 239-335.
13. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991; 78: 55-62.
14. Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun. 1999; 265: 134-9.
15. Quirici N, Soligo D, Bossolasco P, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002; 30: 783-91.
16. Gang EJ, Bosnakovski D, Figueiredo CA, et al. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007; 109: 1743-51.
17. Nesti LJ, Jackson WM, Shanti RM, et al. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. JBone Joint Surg Am. 2008; 90: 2390-8.
18. Fang L, Lange C, Engel M, et al. Sensitive balance of suppressing and activating effects of MSC on T cell proliferation. Transplantation. 2006; 82: 1370-3.
19. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006; 444: 444-54.
20. Polchert D, Sobinsky S, Douglas GW, et al. IFN-γ activation of mesenchymal stem cells for treatment and prevention of graftversushost disease. Eur J Immunol. 2008; 38: 1745-55.
21. Goussetis E, Spiropoulos A, Theodosaki M, et al. Culture of bone marrow CD105+ cells allows rapid selection of pure BM-stromal cells for chimerism studies in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005; 36: 557-9.
22. Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000; 97: 3213-8.
23. Ning H, Yang F, Jiang M, et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia. 2008; 22: 593-9.
24. McMillan ML, Blazar BR, DeFor TE, et al. Transplantation ofex vivoculture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant. 2009; 43: 245-51.
25. Schallmoser K, Rohde E, Reinisch A, et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng. 2008; 14: 185-95.
26. Bartmann C, Rohde E, Schallmoser K, et al. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion. 2007; 47: 1426-35.
27. + cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. Cytotherapy. 2009; 11: 153-62.